What has been going on?
Partnership with The END Fund
Annually, an estimated 4.3 million people in Rwanda require preventive treatment for schistosomiasis. To bolster Rwanda’s plan to end schistosomiasis by 2024, we will provide Rwanda, in partnership with The END Fund, with 8 million additional tablets of the standard medication for the treatment of schistosomiasis per year. The tablets are needed for treating adults endangered by schistosomiasis and will complement our annual donation for the treatment of school-aged children. The END Fund has been a key partner for the Rwandan national strategic plan for neglected tropical diseases (NTDs) in the past and continues to do so through its Deworming Innovation Fund.
Learn more here!
Pediatric Praziquantel Consortium Program
The Pediatric Praziquantel Consortium is an international public-private partnership dedicated to the development of a pediatric formulation to treat schistosomiasis in preschool-age children. The program is in Clinical Phase III stage to acquire confirmatory data for registration.
In early 2021, the Pediatric Praziquantel Consortium celebrated the official launch of its ADOPT program – an implementation research program for approaches for acceptance and equitable access to the pediatric treatment across endemic countries, once it will be registered.
ADOPT: Virtual Launch
Bilharzia Storytelling Lab Kenya
While prevention and control programs have been rolled out in Kenya – including the distribution of medicine – there are still too many people unaware of how to prevent schistosomiasis. During the online workshop, we developed together with Kenyan community leaders and storytellers innovative communication solutions that can creatively improve awareness and access to information. Besides hosting the lab, we are providing seed funding to support the implementation of the best solution.
Nala Partnership extended
We have renewed our partnership with the NALA Foundation – which stands for Neglected Tropical Disease (NTD) Advocacy, Learning, Action – and the Federal Ministry of Health of Ethiopia until 2023 to fight the NTD Schistosomiasis in south-western Ethiopia. Through this project, we will continue to expand our efforts to reach more than 170,000 school-age children in six districts with the highest prevalence of schistosomiasis. Additionally, we will seek to reach 50,000 community members in 8,000 households.
Reaching a milestone
On the first ever World NTD Day we announced and celebrated the major milestone of providing the billionth tablet to WHO. We will continue #MakingSchistory until this devastating disease is eliminated.
A photo story from rural Ethiopia
What is Schistosomiasis?
Schistosomiasis is a water-borne tropical disease caused by parasitic worms. Click below to learn more about it.learn more
Living our Commitment
More than a decade ago we committed ourselves to the fight against schistosomiasis. Learn more about our efforts to eliminate the disease.learn more
R&D for schistosomiasis
We drive and implement R&D programs for innovative drugs, highly sensitive diagnostics, new technologies for safe water access and for controlling transmission of the disease.Learn more